These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 32681818)

  • 1. IVIg and hemolytic anemia risk: dump the anti-A/B already!
    Yazdanbakhsh K; Zhong H
    Transfusion; 2020 Jul; 60(7):1337-1339. PubMed ID: 32681818
    [No Abstract]   [Full Text] [Related]  

  • 2. Intravenous immunoglobulin-induced hemolytic anemia in a patient with juvenile dermatomyositis.
    Clemenz MR; McGowan Iv JW; Shuler MJ; Lynn AW
    J Drugs Dermatol; 2013 Jan; 12(1):111-3. PubMed ID: 23377338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Don't neglect the rare adverse event with intravenous immunoglobulin: Hemolytic anemia.
    Ucar İ; Koyuncu MB; Solmaz AA; Ugurludogan AC; Mercan S; Kucuk M; Unal T; Mazman S; Atilla E
    Transfus Clin Biol; 2023 Feb; 30(1):11-15. PubMed ID: 36028153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous Immunoglobulin-Associated Hemolytic Anemia.
    Jacobs J; Kneib J; Gabbard A
    Lab Med; 2020 Sep; 51(5):e47-e50. PubMed ID: 32339244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemolytic anemia following high dose intravenous immunoglobulin in patients with chronic neurological disorders.
    Markvardsen LH; Christiansen I; Harbo T; Jakobsen J
    Eur J Neurol; 2014; 21(1):147-52. PubMed ID: 24180709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous immunoglobulin-induced hemolytic anemia after thoracoscopic thymectomy for myasthenia gravis.
    Tsukada H; Sunkara R; Chi DD; Keogh D; Gaissert H
    Ann Thorac Surg; 2014 Jun; 97(6):2175-7. PubMed ID: 24882299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute hemolysis secondary to high-dose intravenous immunoglobulin in a patient with Stevens-Johnson syndrome.
    Shakouri AA; Bahna SL
    Ann Allergy Asthma Immunol; 2012 Jun; 108(6):463-4. PubMed ID: 22626604
    [No Abstract]   [Full Text] [Related]  

  • 8. [Insisting on intravenous polyvalent immunoglobulin therapy in polymyositis in spite of the occurrence of sever hemolytic anemia].
    Ballot-Brossier C; Mortelecque R; Sinègre M; Marceau A; Dauriat G; Courtois F
    Transfus Clin Biol; 2001 Apr; 8(2):94-9. PubMed ID: 11386046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous Rh(o) [D] immune globulin [human] (WinRho SDF): suspected hemolytic/renal adverse reactions.
    Parker C
    CMAJ; 2000 Oct; 163(7):881, 885. PubMed ID: 11033724
    [No Abstract]   [Full Text] [Related]  

  • 10. [Adverse effects of intravenous human polyvalent immunoglobulins].
    Chapuis C; Guy N; Besson G
    Rev Neurol (Paris); 2008 Sep; 164 Spec No 3():F203-10. PubMed ID: 18992580
    [No Abstract]   [Full Text] [Related]  

  • 11. Hemolytic anemia associated with intravenous immunoglobulin.
    Wilson JR; Bhoopalam H; Fisher M
    Muscle Nerve; 1997 Sep; 20(9):1142-5. PubMed ID: 9270670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-dose intravenous immunoglobulin is strongly associated with hemolytic anemia in patients with Kawasaki disease.
    Nolan BE; Wang Y; Pary PP; Luban NLC; Wong ECC; Ronis T
    Transfusion; 2018 Nov; 58(11):2564-2571. PubMed ID: 30265742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of intravenous immunoglobulin administration on erythrocyte and leucocyte parameters.
    Cicha A; Fischer MB; Wesinger A; Haas S; Bauer WM; Wolf HM; Sauerwein KMT; Reininger B; Petzelbauer P; Pehamberger H; Handisurya A
    J Eur Acad Dermatol Venereol; 2018 Jun; 32(6):1004-1010. PubMed ID: 29114967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-D immunoglobulin-induced prolonged intravascular hemolysis and neutropenia.
    Alioglu B; Avci Z; Ozyurek E; Ozbek N
    J Pediatr Hematol Oncol; 2007 Sep; 29(9):636-9. PubMed ID: 17805040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Massive intravascular haemolysis after high dose intravenous immunoglobulin therapy.
    Mohamed M; Bates G; Eastley B
    Br J Haematol; 2013 Mar; 160(5):570. PubMed ID: 23294261
    [No Abstract]   [Full Text] [Related]  

  • 16. Severe hemolytic anemia following high-dose intravenous immunoglobulin administration in a patient with Kawasaki disease.
    Nakagawa M; Watanabe N; Okuno M; Kondo M; Okagawa H; Taga T
    Am J Hematol; 2000 Mar; 63(3):160-1. PubMed ID: 10679809
    [No Abstract]   [Full Text] [Related]  

  • 17. Mycoplasma pneumoniae infection associated with hemolytic anemia--report of one case.
    Wang JL; Ho MY; Shen EY
    Acta Paediatr Taiwan; 2004; 45(5):293-5. PubMed ID: 15868814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute hemolysis after high-dose intravenous immunoglobulin therapy in highly HLA sensitized patients.
    Kahwaji J; Barker E; Pepkowitz S; Klapper E; Villicana R; Peng A; Chang R; Jordan SC; Vo AA
    Clin J Am Soc Nephrol; 2009 Dec; 4(12):1993-7. PubMed ID: 19833910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Haemolytic anaemia as a complication to intravenous infusion of human immunoglobulin].
    Juel J; Markvardsen LH; Jakobsen J
    Ugeskr Laeger; 2011 Aug; 173(33):1963-4. PubMed ID: 21849136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-A/B isoagglutinin reduction in an intravenous immunoglobulin product and risk of hemolytic anemia: a hospital-based cohort study.
    Wallenhorst C; Patel A; Shebl A; Hubsch A; Simon TL; Martinez C
    Transfusion; 2020 Jul; 60(7):1381-1390. PubMed ID: 32488887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.